SLFN11 and ovarian carcinoma: In the context of the proven significance of the immune-infiltrating milieu for modulating ovarian cancer prognosis [61,62], the study by Winkler et al. assessed the correlation between not only SLFN11, but also tumor-infiltrating lymphocytes (TILs; evaluated by CD3 and CD8 staining) with outcome in their HGSC patients’ cohort.